NCT04609267

Brief Summary

This study investigates a new delivery method for the Patient Health Questionnaire - 9 (PHQ-9), a clinically accepted tool for diagnosing major depressive disorder. The new tool records auditory responses to the assesment and the study will examine if the instrument is effective at capturing participant depression levels. If proven effective, future studies may investigate if the new format can be used to improve at home clinical care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable major-depressive-disorder

Timeline
Completed

Started Nov 2020

Shorter than P25 for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 30, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

November 3, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

July 8, 2021

Status Verified

July 1, 2021

Enrollment Period

8 months

First QC Date

October 26, 2020

Last Update Submit

July 6, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • PHQ-9 Total Scores

    Measure for Major Depressive Disorder from questionnaire responses

    Immediate

  • User Experience Survey

    26 item questionnaire tracking user experience

    Immediate

Study Arms (2)

Paper Baseline

EXPERIMENTAL

Half of the participants will complete the PHQ-9 in the traditional paper format at their first appointment. At their second appointment 1-month later, they will complete the PHQ-9 on the Mirror device equipped with Amazon Alexa.

Diagnostic Test: PHQ-9 - Mirror format

Mirror Baseline

EXPERIMENTAL

Half of the participants will complete the PHQ-9 on the Mirror device equipped with Amazon Alexa at their first appointment. At their second appointment 1-month later, they will will complete the PHQ-9 in the traditional paper format.

Diagnostic Test: PHQ-9 - Mirror format

Interventions

PHQ-9 - Mirror formatDIAGNOSTIC_TEST

The intervention we will be using is a new delivery system of the PHQ-9 using an Amazon Alexa equipped Mirror device. This Mirror device is similar to a smart television with a mirror interface. The device records auditory responses to the PHQ-9. We will be comparing the responses from the Mirror device to those given on the clinically established paper format.

Also known as: PHQ-9 - Amazon Alexa equipped device
Mirror BaselinePaper Baseline

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly admitted patients to the Oklahoma State University Behavioral Medicine Clinic

You may not qualify if:

  • Vulnerable populations, such as children (i.e., minors or individuals under the legal age of consent) and individuals who are incarcerated (i.e., prisoners), will be excluded.
  • Individuals who are not their own guardian (i.e., those suffering from severe disabilities) will also be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OSU Behavioral Health Clinic

Tulsa, Oklahoma, 75135, United States

RECRUITING

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Jason Beaman, D.O.

    Oklahoma State University Center for Health Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jason Beaman, D.O.

CONTACT

Luke Lawson, M.A.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The study will be counterbalanced with no masking components
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: This study will be a repeated measure, mixed methods design (i.e., it will contain both qualitative and quantitative components). Newly admitted patients will be asked to complete the questionnaires (i.e., PHQ-9 and the UEQ) at two different time points (i.e., Baseline and 1-month follow-up). In order to reduce or control for order effects, the procedure will be counterbalanced.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2020

First Posted

October 30, 2020

Study Start

November 3, 2020

Primary Completion

June 18, 2021

Study Completion

July 31, 2021

Last Updated

July 8, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Aggregate data and findings will be posted on ClinicalTrials.gov.

Locations